Involvement of portosystemic shunts in impaired improvement of liver function after direct-acting antiviral therapies in cirrhotic patients with hepatitis C virus.
Shohei TsujiYoshihito UchidaHayato UemuraJun-Ichi KouyamaKayoko NaikiMasamitsu NakaoDaisuke MotoyaKayoko SugawaraNobuaki NakayamaYukinori ImaiTomoaki TomiyaSatoshi MochidaPublished in: Hepatology research : the official journal of the Japan Society of Hepatology (2020)
A large size of portosystemic shunts was found to be a crucial determinant of impaired improvement of liver function, as well as of the development of portal hypertension-related events, even after sustained viral response in patients with compensated cirrhosis.